These include our results that serum levels of IL-23 were significantly elevated in anti-PD-1 antibody-treated mice with psoriasis-like dermatitis compared to control mice, while the levels were equal between PD-1-deficient mice and WT mice. This evidence concerns the gene IL23A and skin disorder.